Is Hologic Stock Outperforming the Dow?

NodeGuardian

2026-03-20 11:46:36

Abstract generation in progress

Hologic, Inc. (HOLX) has outperformed the Dow Jones Industrials Average ($DOWI) over the past three months, year-to-date, and over the past 52 weeks, despite a recent dip after Q1 2026 results. The company’s stock has risen marginally in these periods while the Dow has seen decreases or lesser returns. Analysts, however, maintain a “Hold” rating on HOLX with a mean price target suggesting only a marginal premium.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.